查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466008

藥物輸送控制釋放市場：按釋放機制、技術和應用分類 - 2024-2030 年全球預測

Controlled Release Drug Delivery Market by Release Mechanism, Technology, Application - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年控釋控制釋放市場規模為430.7億美元，預估2024年將達467億美元，2030年將達796.2億美元，複合年成長率為9.17%。

控制釋放藥物遞送是指以可預測且可控制的速率釋放藥物活性成分的系統。這種藥物輸送方法可以穩定血液中的藥物水平，減少給藥頻率，並提高患者的依從性。控制釋放藥物輸送市場是由在各種應用和最終使用場景中實現這些目標的產品和技術定義的。控制釋放藥物傳遞的應用涵蓋多個治療領域，包括糖尿病、心血管疾病、中樞神經系統疾病、疼痛管理和腫瘤學。影響控制釋放藥物遞送市場成長的挑戰包括與開發新藥物遞送系統相關的高成本以及為特定藥物配製控制釋放藥物遞送系統的技術挑戰。市場正在見證精準醫療方法的進步，這些方法能夠創建適合個別患者需求的藥物輸送系統。此外，新興市場的勢頭明顯，醫療保健基礎設施的擴大和藥物取得的改善正在為控制釋放技術創造新的機會。此外，製藥公司和藥物傳輸技術公司之間的策略合作夥伴關係正在透過促進創新和開發複雜且更有效的藥物輸送機制來重塑格局。

主要市場統計
基準年[2023] 430.7億美元
預測年份 [2024] 467億美元
預測年份 [2030] 796.2億美元
複合年成長率（%） 9.17%

釋放機制：增加研發活動以開發強大的化學活化系統

活化調節的藥物遞送系統旨在在外部或內部觸發因素（例如磁場、超音波、pH 變化和酶）的刺激下釋放藥物。這些系統可以精確控制藥物的釋放曲線，特別有利於靶向體內的特定部位以減少全身副作用。化學活化系統依靠特定的化學反應來觸發藥物釋放，例如特定酶的存在或 pH 水平的變化。這些系統適用於胃腸道治療，因為它們可以調節以激活胃腸道的不同部位。回饋控制系統利用生物或化學反應來控制藥物釋放。依生理需求即時調整藥物釋放，促進個人化醫療。此類系統通常包括與藥物輸送裝置整合的感測器。微儲庫系統由多個小室（儲庫）組成，其中含有受控時間間隔或特定觸發器釋放的藥物。這種方法允許具有不同釋放曲線的多種藥物遞送，並且對於複雜的給藥方案非常有用。基於聚合物的藥物傳遞系統利用生物分解性的聚合物來封裝藥物，並隨著聚合物的分解緩慢釋放藥物。這些系統釋放週期長，適用於慢性疾病。

整合標靶遞送，提高技術治療指數，減少副作用

凝聚是將膠體溶液分離成兩個不同的液相的過程：富含聚合物的凝聚相和缺乏聚合物的上清液。該技術用於封裝藥物，以保護它們免受環境劣化並控制釋放。當活性成分對劣化敏感且需要保護屏障時優先使用。植入是醫療設備，旨在在較長時間內將治療劑直接釋放到作用部位。當需要局部和持續的藥物傳輸時使用它，例如在腫瘤學和荷爾蒙補充療法中。微膠囊化涉及用塗層封裝微小顆粒或液滴，從而賦予微小膠囊有用的特性。標靶遞送旨在透過將活性藥物引導至體內的特定細胞和組織來提高治療指數並減少副作用。當患病部位需要高藥物濃度，同時最大限度地減少全身性藥物暴露時（例如在癌症治療中），該技術是首選。經經皮給藥系統 (TDDS) 透過皮膚給藥，為口服和注射提供了一種非侵入性且方便的替代方案。 TDDS 通常被選用於慢性疾病管理，其中連續給藥具有優勢。 Wurster 製程是流體化床包衣的子集，廣泛應用於製藥領域，對顆粒、丸劑和顆粒進行包衣，以實現控制釋放。此方法適用於需要均勻包覆和精確控制釋放動力學的藥物。

應用實例 慢性病管理中越來越偏好注射控制釋放給藥系統

藥物洗脫支架是心臟病學中使用的控制釋放藥物輸送的一個突出例子。透過將藥物合併到支架結構中，這些裝置在血管成形術期間被放置到狹窄的冠狀動脈中。隨著時間的推移，藥物會緩慢釋放，防止手術後動脈血管再阻塞（血管再阻塞）。輸液幫浦是醫療設備，旨在以受控方式將液體（包括營養物和藥物）輸送到患者體內。這些幫浦可用於各種醫療保健環境，包括醫院、療養院和家庭護理患者。能夠控制藥物傳遞的時間、速率和持續時間有助於維持血液中的治療藥物水平，這對於化療、疼痛管理和抗生素給藥等治療至關重要。注射控制釋放系統提供了一種先進的藥物傳遞方法，特別是對於全身性效應和標靶治療。這些系統通常使用封裝的藥物顆粒或生物分解性的聚合物，它們會隨著時間的推移而分解，以指定的速率釋放藥物。定量吸入器是設計用於將特定量的藥物輸送到肺部的裝置，通常用於治療氣喘和慢性阻塞性肺病等呼吸系統疾病。與全身給藥相同的藥物相比，MDI 的控制釋放機制可確保精確劑量、快速起效並減少全身副作用，從而有效管理患者病情。口服藥物遞送是最常見的控制釋放技術之一。它們有多種劑型，如錠劑、膠囊和薄膜，可控制藥物從消化道釋放和吸收的速率。經皮吸收貼片和眼用貼片代表了一類獨特的控制釋放藥物傳遞系統。經皮吸收貼片透過皮膚輸送藥物，可以長時間穩定地釋放藥物，最大限度地減少尖峰時段波動並提高患者的舒適度。

區域洞察

由於大型製藥公司和先進的醫療基礎設施的存在，美洲（尤其是北美）的控制釋放給藥市場已十分成熟。由於 FDA 對新型藥物輸送系統的支持以及需要長期治療的慢性病的高盛行率，美國在市場上佔有重要地位。由於歐洲藥品管理局 (EMA) 管理的強大法律規範，歐洲在藥物輸送控制釋放市場中佔有重要佔有率。市場受益於政府的醫療保健政策以及專利懸崖導致的學名藥的崛起。由於經濟發展、醫療基礎設施投資以及先進治療選擇的增加，中東和非洲顯示出成長潛力。由於中國和印度等國家製藥業的擴張和醫療保健支出的增加，預計亞太地區控制釋放領域將快速成長。解決許多患者未滿足的醫療需求正受到越來越多的關注。國內外公司之間的合作以及政府對促進學名藥使用的支持為該地區提供了成長機會。

FPNV定位矩陣

FPNV定位矩陣對於評估控釋控制釋放市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對控制釋放市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.控釋控制釋放市場的市場規模與預測是多少？

2.控釋控制釋放市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3.控釋控制釋放市場的技術趨勢與法規結構是什麼？

4.控釋控制釋放市場主要廠商的市場佔有率為何？

5. 進入控制釋放市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 嬰幼兒和老年人對控制釋放製劑的需求不斷增加
      • 擴大採用水凝膠和滲透控制藥物傳輸系統
      • 需要提高治療功效並降低藥物毒性以控制各種疾病。
    • 抑制因素
      • 藥物輸送控制釋放系統的複雜製造程序
    • 機會
      • 奈米技術在先進醫學/控制釋放藥物傳輸系統製劑的潛在發展
      • 控釋藥物傳輸系統的進展
    • 任務
      • 控釋藥物製劑的潛在局限性
  • 市場區隔分析
    • 釋放機制：加強研發力度，發展強大的化學活化系統
    • 技術：整合標靶遞送以提高治療指數並減少副作用
    • 應用：注射緩釋性給藥系統在慢性病管理中日益普及
  • 市場趨勢分析
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化

第6章依釋放機制控制釋放市場

  • 活化調變藥物輸送系統
  • 化學活化
  • 回饋控制給藥系統
  • 微儲庫分區控制給藥系統
  • 基於聚合物的系統

第7章藥物輸送控制釋放市場：依技術分類

  • 凝聚
  • 植入
  • 微膠囊化
  • 定向投放
  • 經皮的
  • 阿爾斯特技術

第8章藥物輸送控制釋放市場：依應用分類

  • 藥物釋放型支架
  • 點滴幫浦
  • 可注射的
  • 定量吸入器
  • 口服控釋給藥系統
  • 經皮吸收貼片和眼科貼劑

第 9 章：美洲藥物輸送控制釋放市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太給藥控制釋放市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的藥物傳輸控制釋放市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • DelSiTech 宣布完成 1,000 萬歐元資金籌措，以推進其基於二氧化矽的藥物輸送技術平台
    • Chiesi 全球罕見疾病與 Aliada Therapeutics 合作推動跨血腦障壁藥物傳遞平台技術

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-A339DAEFA6EE

[196 Pages Report] The Controlled Release Drug Delivery Market size was estimated at USD 43.07 billion in 2023 and expected to reach USD 46.70 billion in 2024, at a CAGR 9.17% to reach USD 79.62 billion by 2030.

Controlled-release drug delivery refers to systems that release the active ingredient of a drug at a predictable and controllable rate. This approach to drug delivery ensures a steady level of medication in the bloodstream, reduces the frequency of dosing, and can improve patient compliance. The market for controlled-release drug delivery is defined by products and technologies that accomplish these objectives across various applications and end-use scenarios. Applications for controlled-release drug delivery span multiple therapeutic areas, such as diabetes, cardiovascular diseases, CNS disorders, pain management, and oncology. Challenges affecting the growth of the controlled-release drug delivery market involve High costs associated with developing new drug delivery systems and Technical challenges in formulating controlled-release drug delivery systems for certain drugs. The market is witnessing the advancement of precision medicine approaches that enable the creation of tailored drug delivery systems for individual patient needs. Additionally, there is an apparent momentum in emerging markets where the expansion of healthcare infrastructures and improved access to pharmaceuticals are generating new opportunities for controlled-release technologies. Furthermore, the landscape is being reshaped by strategic partnerships between pharmaceutical enterprises and drug-delivery technology firms, fostering innovation and the development of sophisticated, more effective drug-delivery mechanisms.

KEY MARKET STATISTICS
Base Year [2023] USD 43.07 billion
Estimated Year [2024] USD 46.70 billion
Forecast Year [2030] USD 79.62 billion
CAGR (%) 9.17%

Release Mechanism: Increasing R&D activities for development of robust chemically activated system

Activation-modulated drug delivery systems are designed to release the drug upon stimulation by external or internal triggers such as magnetic fields, ultrasound, pH changes, or enzymes. These systems offer precise control over the release profile of the drug and are particularly beneficial in targeting specific sites within the body, reducing systemic side effects. Chemically activated systems rely on specific chemical reactions to trigger drug release, such as the presence of certain enzymes or changes in pH levels. These systems are well-suited for gastrointestinal treatments as they can be tailored to activate in different parts of the GI tract. Feedback regulated systems use biological or chemical responses to control drug release. The drug release is adjusted in real-time based on physiological demand, promoting personalized medicine. Such systems usually involve sensors integrated with drug-delivery devices. Micro reservoir systems consist of multiple tiny compartments (reservoirs) containing the drug, which are released at controlled intervals or upon specific triggers. This approach allows for the delivery of multiple drugs with different release profiles and is useful for complex medication regimens. Polymer-based drug delivery systems utilize biodegradable polymers to encase the drug, releasing it slowly as the polymer degrades. These systems offer prolonged release periods and are well-suited for chronic conditions.

Technology: Integration of targeted delivery to increase therapeutic index and reducing side effects

Coacervation is a process that involves the separation of colloidal solutions into two distinct liquid phases: a polymer-rich coacervate phase and a polymer-poor supernatant. This technology is used for encapsulating drugs to protect them from environmental degradation and to control their release. It is preferentially used when the active ingredient is sensitive to degradation and requires a protective barrier. Implants are medical devices designed to release therapeutic agents directly into the site of action over an extended period. They are employed when localized, continuous drug delivery is desired, such as in oncology or hormone replacement therapies. Microencapsulation involves encapsulating tiny particles or droplets with a coating to give small capsules useful properties. Targeted delivery aims to direct the active drug to specific cells or tissues in the body, thereby increasing the therapeutic index and reducing side effects. This technology is preferred for conditions requiring high drug concentrations at the disease site while minimizing systemic exposure, such as in cancer treatments. Transdermal drug delivery systems (TDDS) administer drugs through the skin, providing a non-invasive and convenient alternative to oral and injectable routes. TDDS is typically chosen for chronic disease management where continuous drug administration is advantageous. The Wurster Technique is a subset of fluidized bed coating used extensively in pharmaceuticals for coating granules, pellets, or particles to achieve a controlled release of the drug. This method is well-suited for drugs that require a uniform coating and precise control over the release kinetics.

Application: Rising preference for injectable controlled-release drug delivery systems for chronic disease management

Drug-eluting stents are a remarkable implementation of controlled-release drug delivery used in cardiology. By incorporating medication into the stent's structure, these devices are placed into narrowed, diseased coronary arteries during angioplasty. The drugs are released slowly over time to prevent restenosis, the re-narrowing of the arteries after the procedure. Infusion pumps are medical devices designed to deliver fluids, including nutrients and medications, into a patient's body in a controlled manner. These pumps can be used in a variety of healthcare settings, including hospitals, nursing homes, and even for patients in home care. The ability to control the timing, rate, and duration of delivery helps in maintaining therapeutic drug levels in the bloodstream, which is essential for treatments such as chemotherapy, pain management, and the administration of antibiotics. Injectable controlled release systems offer a sophisticated approach to drug delivery, particularly for systemic effects or targeted therapy. These systems often involve encapsulated drug particles or biodegradable polymers that degrade over time, releasing the drug at a predetermined rate. Metered Dose Inhalers are devices designed to deliver specific amounts of medication to the lungs, commonly used to treat respiratory conditions such as asthma and COPD. The controlled release mechanism in MDIs allows patients to manage their conditions effectively by ensuring precise dosing, rapid onset of action, and reduced systemic side effects compared to systemic administration of the same drugs. Oral controlled-drug delivery systems are one of the most common forms of controlled-release technologies available. They incorporate various formulations such as tablets, capsules, or films that control the rate at which the digestive system releases and absorbs the drug. Transdermal and ocular patches represent a unique controlled-release drug delivery system segment. Transdermal patches administer medication through the skin, allowing for a steady drug release over an extended period, minimizing peak-trough fluctuations and improving patient comfort.

Regional Insights

The controlled-release drug delivery market in the Americas, particularly North America, is well-established due to the presence of key pharmaceutical companies and advanced healthcare infrastructure. The United States holds a significant position in the market, owing to FDA support for novel drug delivery systems and a higher prevalence of chronic diseases, which necessitate prolonged drug administration. Europe holds a substantial share in the controlled release drug delivery market, with a strong regulatory framework governed by the European Medicines Agency (EMA). The market benefits from favorable government healthcare policies and the rise of generics due to patent cliffs. The Middle East and Africa exhibit potential growth due to economic development, investment in healthcare infrastructure, and increasing accessibility to advanced treatment options. Asia-Pacific is expected to experience rapid growth in the controlled-release drug delivery sector due to the expanding pharmaceutical industry and rising healthcare expenditure in countries such as China and India. There is an increasing focus on addressing the unmet medical needs of a large patient population. Partnerships between local and international players and governmental support in promoting generic drug use offer growth opportunities in this region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Controlled Release Drug Delivery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Controlled Release Drug Delivery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Controlled Release Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include Adare Pharma Solutions, Alkermes PLC, AMW GmbH, AstraZeneca PLC, Avantor, Inc., Baxter International Inc., Becton, Dickinson and Company, Biogen Inc., Boehringer Ingelheim International GmbH, Catalent, Inc., Celanese Corporation, Celares GmbH, Coating Place, Inc., Collegium Pharmaceutical, Inc., Colorcon, Inc., Corium, Inc., CURE Pharmaceutical, GlaxoSmithKline PLC, Insulet Corporation, Johnson & Johnson Services, Inc., Lonza Group Ltd., Medtronic PLC, Merck & Co., Inc., Pensatech Pharma GmbH, Pfizer Inc., Seqens, Tandem Diabetes Care, Inc., and Trelleborg AB.

Market Segmentation & Coverage

This research report categorizes the Controlled Release Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Release Mechanism
    • Activation-Modulated Drug Delivery Systems
      • Hydrodynamic Pressure Activated
      • Magnetically Activated
      • Mechanically Activated
      • Osmotic Pressure Activated
      • Vapor Pressure Activated
    • Chemically Activated
      • Enzyme Activated
      • Hydrolysis Activated
      • pH Activated
    • Feedback Regulated Drug Delivery Systems
    • Micro Reservoir Partition Controlled Drug Delivery Systems
    • Polymer Based Systems
  • Technology
    • Coacervation
    • Implants
    • Micro Encapsulation
    • Targeted Delivery
    • Transdermal
    • Wurster Technique
  • Application
    • Drug Eluting Stents
    • Infusion Pumps
    • Injectable
    • Metered Dose Inhalers
    • Oral Controlled-Drug Delivery Systems
    • Transdermal & Ocular Patches
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Controlled Release Drug Delivery Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Controlled Release Drug Delivery Market?

3. What are the technology trends and regulatory frameworks in the Controlled Release Drug Delivery Market?

4. What is the market share of the leading vendors in the Controlled Release Drug Delivery Market?

5. Which modes and strategic moves are suitable for entering the Controlled Release Drug Delivery Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in Need for Controlled Release Dosage Forms for the Infants and Geriatric Population
      • 5.1.1.2. Rising Adoption of Hydrogel and Osmotic Controlled Drug Delivery System
      • 5.1.1.3. Need to Improve the Therapeutic Benefits, Reduce Drug Toxicity to Control Various Types of Illness
    • 5.1.2. Restraints
      • 5.1.2.1. Complex Manufacturing Process of Controlled Release Drug Delivery System
    • 5.1.3. Opportunities
      • 5.1.3.1. Potential Development of Nanotechnology in Advanced Medicine/Drug Formulations for Controlled-Release Drug Delivery System
      • 5.1.3.2. Advances in Control Release Drug Delivery System
    • 5.1.4. Challenges
      • 5.1.4.1. Potential limitation of controlled drug release formulation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Release Mechanism: Increasing R&D activities for development of robust chemically activated system
    • 5.2.2. Technology: Integration of targeted delivery to increase therapeutic index and reducing side effects
    • 5.2.3. Application: Rising preference for injectable controlled-release drug delivery systems for chronic disease management
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Controlled Release Drug Delivery Market, by Release Mechanism

  • 6.1. Introduction
  • 6.2. Activation-Modulated Drug Delivery Systems
  • 6.3. Chemically Activated
  • 6.4. Feedback Regulated Drug Delivery Systems
  • 6.5. Micro Reservoir Partition Controlled Drug Delivery Systems
  • 6.6. Polymer Based Systems

7. Controlled Release Drug Delivery Market, by Technology

  • 7.1. Introduction
  • 7.2. Coacervation
  • 7.3. Implants
  • 7.4. Micro Encapsulation
  • 7.5. Targeted Delivery
  • 7.6. Transdermal
  • 7.7. Wurster Technique

8. Controlled Release Drug Delivery Market, by Application

  • 8.1. Introduction
  • 8.2. Drug Eluting Stents
  • 8.3. Infusion Pumps
  • 8.4. Injectable
  • 8.5. Metered Dose Inhalers
  • 8.6. Oral Controlled-Drug Delivery Systems
  • 8.7. Transdermal & Ocular Patches

9. Americas Controlled Release Drug Delivery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Controlled Release Drug Delivery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Controlled Release Drug Delivery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. DelSiTech Announces Closing of EUR 10 Million Financing Round to Advance its Silica-Based Drug Delivery Technology Platform
    • 12.3.2. Chiesi Global Rare Diseases and Aliada Therapeutics Partner to Advance Blood-Brain Barrier-Crossing Platform Technology for Drug Delivery

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH PROCESS
  • FIGURE 2. CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CONTROLLED RELEASE DRUG DELIVERY MARKET DYNAMICS
  • FIGURE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CONTROLLED RELEASE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CONTROLLED RELEASE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDRODYNAMIC PRESSURE ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDRODYNAMIC PRESSURE ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MAGNETICALLY ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MAGNETICALLY ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MECHANICALLY ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MECHANICALLY ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY OSMOTIC PRESSURE ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY OSMOTIC PRESSURE ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY VAPOR PRESSURE ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY VAPOR PRESSURE ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ENZYME ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ENZYME ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDROLYSIS ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDROLYSIS ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PH ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PH ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY FEEDBACK REGULATED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY FEEDBACK REGULATED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO RESERVOIR PARTITION CONTROLLED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO RESERVOIR PARTITION CONTROLLED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER BASED SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER BASED SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COACERVATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COACERVATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY IMPLANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO ENCAPSULATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO ENCAPSULATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY WURSTER TECHNIQUE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY WURSTER TECHNIQUE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INJECTABLE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ORAL CONTROLLED-DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ORAL CONTROLLED-DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL & OCULAR PATCHES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL & OCULAR PATCHES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 164. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 165. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 166. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 174. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 175. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 176. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 177. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 178. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 184. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 185. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 186. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 187. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 188. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 189. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 190. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 194. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 195. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 196. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 197. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 198. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 199. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 200. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 201. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 204. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 206. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 208. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 209. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 210. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 214. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 215. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 216. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 217. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 218. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 219. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 220. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 221. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 224. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 225. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 226. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 227. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 228. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 229. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 234. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 235. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 236. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 237. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 238. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 239. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 240. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 241. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 244. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 245. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 246. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 247. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 248. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 249. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 250. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 251. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 254. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 255. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 256. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 257. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 258. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 259. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 260. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 261. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 262. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 275. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
  • TABLE 276. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
  • TABLE 277. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
  • TABLE 278. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
  • TABLE 279. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
  • TABLE 280. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
  • TABLE 281. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLIO